This bill amends Arkansas Code Title 17, Chapter 92, Subchapter 1, to establish regulations for outsourcing facilities that compound legend drugs and controlled substances. It introduces a new section, 17-92-121, which defines an "outsourcing facility of legend drugs and controlled substances" as an entity registered as a 503B outsourcing facility with the FDA and holding a permit from the Arkansas State Board of Pharmacy. The bill allows these facilities to sell compounded products to specific entities, including Arkansas-licensed retail pharmacies, healthcare facilities, and healthcare providers, while prohibiting sales to wholesale distributors and other entities.

Additionally, the bill mandates that outsourcing facilities comply with the Current Good Manufacturing Practices regulations as outlined in federal law, specifically referencing 21 C.F.R. Parts 210, 211, and 212, effective from January 1, 2025. This legislation aims to ensure the safe and regulated distribution of compounded medications while maintaining strict compliance with established manufacturing standards.